Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study is designed to establish the effect of 2 doses of vonafexor on the kidney. This will be investigated in subjects with mild or moderate reduced estimated glomerular filtration rate (eGFR) and suspected MASH. In addition, the non-invasive multiparametric magnetic resonance imaging assessment of functional and structural changes in the kidney and in the liver will be investigated.
Epistemonikos ID: 65f32de686ab0b64430c0717d76dc2f6139a65f0
First added on: Apr 24, 2025